Track the Lumos Diagnostics Holdings Limited share price and the full directors' dealings record of the company, a listed issuer based in Australia. Shares trade on AU AU, under the oversight of ASX. Operating in the Health Care sector, Lumos Diagnostics Holdings Limited has published 3 reports. Market capitalisation: €99.2m. The latest transaction was reported on 25 June 2026 (Purchase). Among the most active insiders: Unknown. All data is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Lumos Diagnostics Holdings Limited is a company focused on the development of rapid diagnostic tests. It is listed on the XASX market.